MEDICINE

This was an unusual circumstance that had a couple panicking.

An Adderall shortage is affecting some who live with Attention-deficit/Hyperactivity Disorder (ADHD), both locally and nationwide.

Four lots of Quinapril Tablets are being recalled by Lupin Pharmaceuticals Inc. due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, according to the FDA.

“It’s another tool in our toolbox," said Senior Vice President and Chief Medical Information Officer, Dr. Stephen Morga. The grant allows Carilion to create Virtual Care Centers so patients who live far away from specialty doctors can go to a medical office closer to home. “Folks that have to take a bus or don’t have their own transportation really find it hard to get in routinely for medical care. Carilion plans to educate patients about the technology so they could use it from home. Carilion plans to implement the changes and technology starting at the beginning of 2021.

The ships were deployed in late March to help assist frontline hospital workers and provide care on the ships, should hospitals overflow with patients. Comfort arrived in New York City on March 30, a day after it left Virginia, according to Business Insider. Comfort left New York City after treating 182 patients, 70% of whom had COVID-19, according to NavyTimes. Comfort is available in case it is needed for future help, according to NavyTimes, while USNI News reported the same is true for Mercy. (Getty Images)The USNS Comfort departs for its home port of Norfolk, Virginia on April 30, 2020 in New York City.

There is no research or data to suggest ibuprofen is dangerous for someone with COVID-19 to use. While officials don’t know the exact source of COVID-19, they know the first infections were linked to a live animal market. So far, there’s no evidence that COVID-19 is spread through semen or vaginal fluids, according to Planned Parenthood. Therefore, it would be easy to get COVID-19 if you have in-person sexual contact with someone who has it. If not, click here to let us know what you’d like to find out about the novel coronavirus.

How long do experts forecast for a COVID-19 vaccine to be created? Moderna, one of the U.S. companies working on a vaccine, said it could have a vaccine ready for a phase one clinical trial in people within three months. Phase I vaccine trials - This is the first attempt to try out the vaccine in a small group of adults -- usually 20 to 80 subjects. Phase II vaccine trials - The vaccine is tested on a larger group of individuals to assess the safety of the vaccine and method of delivery. Phase III vaccine trials - If the vaccine passed the first two phases, it’s then tested on tens of thousands of people to make sure there are few adverse side effects and the vaccine is effective.